logo
Overview
Discover
Watchlists
Portfolios
Heatmap
Sectors
Trendscore
Performers
Alerts
Options
Earnings
Screeners
Scanners
Backtests
Strategies
Comparisons
Charts
Sign in
Discover

OGN
Organon & Co.
13.68
213200 x undefined
42500 x undefined
bid
ask
-
0.01
0.07%
2 @ 04:14 AM
13.73 +0.05 (0.40%)
Ytd90.79%
1y26.08%
13.68
day range
13.70
5.69
52 week range
13.79
Open13.68Prev Close13.69Low13.68High13.70Mkt Cap3.59B
Vol4.94MAvg Vol2.75MEPS0.78P/E17.54Forward P/E3.78
Beta1.52Short Ratio5.80Inst. Own84.81%Dividend0.08Div Yield0.58
Ex Div Date08-14Earning11-0950-d Avg13.64200-d Avg10.561yr Est11.25

OGN News

VIRGINIA RETIREMENT SYSTEMS ET Al Makes New $770,000 Investment in Organon & Co. $OGN
defenseworld.net
VIRGINIA RETIREMENT SYSTEMS ET Al Makes New $770,000 Investment in Organon & Co. $OGN

VIRGINIA RETIREMENT SYSTEMS ET Al purchased a new stake in shares of Organon and Co. (NYSE: OGN) in

Organon Announces US FDA Has Accepted for Review a Supplemental New Drug Application for MIUDELLA®, a Hormone-Free Intrauterine Device
businesswire.com
Organon Announces US FDA Has Accepted for Review a Supplemental New Drug Application for MIUDELLA®,

JERSEY CITY, N.J.--(BUSINESS WIRE)--Organon announces FDA accepts MIUDELLA® sNDA for review, seeking